I’ll say I am skeptical of claim that sub-q results in higher levels of T and less aromatization to any significant degree. I remember when a study came out that supported that claim, but IMO the study’s methodology was flawed (comparing apples and oranges). I think a lot of people drew conclusions that were in error from that study.
Maybe I am remembering wrong. Please correct me if so. The study compared once a week IM, to twice a week sub-Q. On the same dose twice a week injections will result in higher trough T levels, as well, it is likely that E2 will be lower with more injection frequency. I have a trouble crediting the sub-Q injection for these benefits compared to the injection frequency. It could be all the injection frequency doing the work, it could be a bit of both, it could be the sub-Q, but I just don’t think we can sort that out from the study. Perhaps there is research I haven’t seen, and I am jumping to the conclusion you are thinking of the same study as I am?